Ariad's "Poison Pill" Plan Comes After Former Icahn Exec Buys Stake
Investors seem boyed by Ariad Pharmaceuticals’ decision Friday to adopt a plan designed to prevent takeovers, raising the company’s stock price 22 percent since the Friday morning announcement...
Related Articles
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Agios Scores Biogen CFO as Board Member also written by Don Seiffert
- Care.com Shutting Down e-Commerce Firm it Previously Acquired, Loses Board Member also published in Business News
- Ariad CEO to Retire Due to Pressure From Shareholders also written by Don Seiffert
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Why State Street is Giving Shareholders a Bigger Say over Its Board also published in Business News
- Analyst: Icahn May Urge Separation of CEO. Chairman Roles at Nuance also written by Don Seiffert
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Ford Fires CEO Mark Fields; Former Steelcase Chief Jim Hackett To Take Over also categorized in BoardNews
- Verastem directors buy $475K of stock, company set for potential pivotal trials also written by Don Seiffert
Login to comment.